Archive for the ‘About’ Category

Google Scholar Publications Michael A. S. Guth

An Independent Review of Camrelizumab-Rivoceranib Combination Therapy for the Treatment of Hepatocellular Carcinoma and Rivoceranib for Gastric Cancer. Biomedical Journal of Sci & Tech Res, 58(2) (Aug 2024). https://biomedres.us/fulltexts/BJSTR.MS.ID.009118.php Surgical Implantation of Autologous Dopamine Neuron Progenitor Cells (DANPCs) Into the Putamen of Patients with Parkinsonโ€™s Disease, Surgical Medicine Open Access Journal, (December 2024), Compounded Tirzepatide […]

“๐ˆ๐Ÿ ๐ฒ๐จ๐ฎ ๐š๐ซ๐ž ๐ฐ๐จ๐ซ๐ค๐ข๐ง๐  ๐จ๐ง ๐ฌ๐จ๐ฆ๐ž๐ญ๐ก๐ข๐ง๐  ๐ญ๐ก๐š๐ญ ๐ฒ๐จ๐ฎ ๐ซ๐ž๐š๐ฅ๐ฅ๐ฒ ๐œ๐š๐ซ๐ž ๐š๐›๐จ๐ฎ๐ญ, ๐ฒ๐จ๐ฎ ๐๐จ๐งโ€™๐ญ ๐ก๐š๐ฏ๐ž ๐ญ๐จ ๐›๐ž ๐ฉ๐ฎ๐ฌ๐ก๐ž๐. ๐“๐ก๐ž ๐ฏ๐ข๐ฌ๐ข๐จ๐ง ๐ฉ๐ฎ๐ฅ๐ฅ๐ฌ ๐ฒ๐จ๐ฎ.” โ€”๐’๐ญ๐ž๐ฏ๐ž ๐‰๐จ๐›๐ฌ

True momentum does not come from forced oversight, rigid deadlines, or endless motivation hacks. When a mission genuinely resonates with your core values and intellect, the dynamic shifts entirely from external pressure to internal gravity. The destination itself acts as an irresistible force, aligning your energy naturally toward the outcome. In complex fields like health […]

TAX508 Personal Income Taxation (Summer Term 2026)

I am pleased to share that for the summer 2026 academic term, I am teaching TAX508: Taxation of Individuals at William Howard Taft University. This graduate-level course provides a comprehensive framework for navigating the complex statutory, regulatory, and judicial realities governing federal individual income taxation. Guided by the fundamental powers established under the Sixteenth Amendment, […]

Alzheimer’s Dual Sequestration Hypothesis

๐๐ž๐ฐ ๐๐ฎ๐›๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐…๐ซ๐ž๐ž ๐๐ž๐ฎ๐ซ๐จ๐ฉ๐š๐ญ๐ก๐จ๐ฅ๐จ๐ ๐ฒ (๐‰๐ฎ๐ง๐ž ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”) ๐ˆ ๐š๐ฆ ๐ฉ๐ฅ๐ž๐š๐ฌ๐ž๐ ๐ญ๐จ ๐ฌ๐ก๐š๐ซ๐ž ๐จ๐ฎ๐ซ ๐ฅ๐š๐ญ๐ž๐ฌ๐ญ ๐œ๐ฅ๐ข๐ง๐ข๐œ๐จ๐ฉ๐š๐ญ๐ก๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐ฎ๐ฉ๐๐š๐ญ๐ž ๐š๐๐๐ซ๐ž๐ฌ๐ฌ๐ข๐ง๐  ๐š ๐ฉ๐ž๐ซ๐ฌ๐ข๐ฌ๐ญ๐ž๐ง๐ญ ๐ฉ๐š๐ซ๐š๐๐จ๐ฑ ๐ข๐ง ๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ’๐ฌ ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž: ๐ฐ๐ก๐ฒ ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ข๐ž๐ฌ ๐ญ๐š๐ซ๐ ๐ž๐ญ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ซ๐ž๐ฆ๐จ๐ฏ๐š๐ฅ ๐จ๐Ÿ ๐š๐ฆ๐ฒ๐ฅ๐จ๐ข๐-ฮฒ ๐ฉ๐ฅ๐š๐ช๐ฎ๐ž๐ฌ ๐š๐ง๐ ๐ญ๐š๐ฎ ๐ญ๐š๐ง๐ ๐ฅ๐ž๐ฌ ๐œ๐จ๐ง๐ฌ๐ข๐ฌ๐ญ๐ž๐ง๐ญ๐ฅ๐ฒ ๐ฌ๐ก๐จ๐ฐ ๐š ๐œ๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐๐ข๐ฌ๐ฌ๐จ๐œ๐ข๐š๐ญ๐ข๐จ๐ง ๐Ÿ๐ซ๐จ๐ฆ ๐œ๐จ๐ซ๐ž ๐œ๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐ฉ๐š๐ญ๐ก๐จ๐ ๐ž๐ง๐ž๐ฌ๐ข๐ฌ. ๐ˆ๐ง “๐€๐ฅ๐ณ๐ก๐ž๐ข๐ฆ๐ž๐ซ’๐ฌ ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ข๐ง ๐ญ๐ก๐ž ๐๐ฅ๐š๐ฌ๐ญ๐ข๐œ๐ž๐ง๐ž ๐ž๐ซ๐š: ๐š ๐œ๐ฅ๐ข๐ง๐ข๐œ๐จ๐ฉ๐š๐ญ๐ก๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐ฎ๐ฉ๐๐š๐ญ๐ž ๐จ๐ง ๐ญ๐ก๐ž […]

National Alzheimer’s Prevention Policy

“๐‰๐ฎ๐๐ ๐ž ๐š ๐ฆ๐š๐ง ๐›๐ฒ ๐ก๐ข๐ฌ ๐ช๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐ซ๐š๐ญ๐ก๐ž๐ซ ๐ญ๐ก๐š๐ง ๐›๐ฒ ๐ก๐ข๐ฌ ๐š๐ง๐ฌ๐ฐ๐ž๐ซ๐ฌ.” – ๐•๐จ๐ฅ๐ญ๐š๐ข๐ซ๐žย  ย  ย So hereโ€™s my question: Should a national policy treat perfectly healthy, โ€œat riskโ€ people for Alzheimerโ€™s before they show a single symptom? Iโ€™ve spent the last several months researching and writing exactly that โ€” a new national prophylaxis framework for Alzheimerโ€™s […]

Accelerating the Orphan GPCR Pipeline: GPR149 as a Case Study in Dual-Domain Target Validation

https://doi.org/10.1016/j.drudis.2026.104678ย  Free download of the article using this link until June 16:ย  https://authors.elsevier.com/a/1n0uP4r9Rkz1l6 Highlights New four-pillar framework accelerates deorphanization of dark GPCR targets. (77 chars) GPR149 structural analysis identifies non-canonical ERY and DPxxF motifs. (76 chars) Path-agnostic screening bypasses traditional Gi/oย signaling limitations. (75 chars) Integrated CNS and metabolic mapping reveals GPR149โ€ฒs dual-domain value. (76 chars) […]

In the 1950s, my physicist father met with Albert Einstein at the Institute for Advanced Study to discuss unified field theory.

In the 1950s, my physicist father, Eugene Guth, met with Albert Einstein at the Institute for Advanced Study to discuss unified field theory. Einstein, it turned out, was more interested in the philosophy of physics than the math, a topic equally of interest to my dad.ย  See https://michaelguth.com/family/HistoryofPhysicsbyEugeneGuth.htm Mathematics and philosophy of physics have relevance […]

๐…๐จ๐œ๐ฎ๐ฌ๐ข๐ง๐  ๐จ๐ง ๐›๐ž๐ญ๐ญ๐ž๐ซ ๐š๐ฅ๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐ฏ๐ž๐ฌ ๐ญ๐จ ๐ฌ๐ก๐ข๐ฉ๐ฉ๐ข๐ง๐  ๐จ๐Ÿ๐Ÿ ๐ž๐ฅ๐๐ž๐ซ๐ฅ๐ฒ ๐ฉ๐š๐ซ๐ž๐ง๐ญ๐ฌ ๐ญ๐จ ๐ง๐ฎ๐ซ๐ฌ๐ข๐ง๐  ๐ก๐จ๐ฆ๐ž๐ฌ

๐…๐จ๐œ๐ฎ๐ฌ๐ข๐ง๐  ๐จ๐ง ๐›๐ž๐ญ๐ญ๐ž๐ซ ๐š๐ฅ๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐ฏ๐ž๐ฌ ๐ญ๐จ ๐ฌ๐ก๐ข๐ฉ๐ฉ๐ข๐ง๐  ๐จ๐Ÿ๐Ÿ ๐ž๐ฅ๐๐ž๐ซ๐ฅ๐ฒ ๐ฉ๐š๐ซ๐ž๐ง๐ญ๐ฌ ๐ญ๐จ ๐ง๐ฎ๐ซ๐ฌ๐ข๐ง๐  ๐ก๐จ๐ฆ๐ž๐ฌ. Moira Welsh’sย HAPPILY EVER OLDERย is a hopeful investigative work that serves as a “blueprint for change” in long-term careย . Instead of focusing on common horror stories, Welsh travels across North America and Europe to find facilities that have successfully replaced institutional “warehousing” with vibrant […]

The Institute for Neuroplasticity Research is dedicated to pioneering the next frontier of neurological therapeutics by harnessing the brain’s innate capacity for change. We operate at the critical intersection of advanced science and strategic development, focusing on transformative modalities likeย Cell Replacement Therapyย and novel neuromodulation. Our core mission is to de-risk and accelerate the path of […]